The Department of Immunology and Immunotherapy and the Icahn Genomics Institute (IGI) at the Icahn School of Medicine at Mount Sinai have been awarded a $5 million grant from the National Cancer Institute (NCI) of the National Institutes of Health to establish a state-of-the-art center dedicated to the discovery and development of cutting-edge targets for cancer therapy.
The title of the NCI grant is “Spatial functional genomics to Identify Regulators of the Tumor Microenvironment and cancer immunity (grant number 1U01CA282114-01).
Free access provides up to 10 articles
Subscription options start at $5 per month
which is less than a Starbucks coffee!